13/10/2026
Are we recognising the opportunity for cancer prevention at the point of infection diagnosis?
The clinical relationship between chronic infections and malignancy places molecular diagnostics at an important intersection of infectious disease and oncology.
In our latest blog, BioCipher explores how identifying H. pylori, high-risk HPV, HBV, HCV and EBV can inform infection management, risk assessment and appropriate surveillance.
For doctors, clinicians, hospitals and diagnostic centres, we discuss the role of multiplex molecular testing, genotyping, resistance markers and AI-assisted interpretation in supporting these clinical decisions.
Read the full blog to explore BioCipherโs Onco-Infection frameworkโand how infection-focused diagnostics can contribute to preventive oncology ๐๐ป
https://biocipher.ai/the-infection-cancer-nexus-redefining-preventive-oncology-through-molecular-diagnostics/